AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)Seeking Alpha • 07/30/23
AstraZeneca Shares Surge After Revenue Beat on Cancer Drug Sales, $1 Billion Pfizer DealInvestopedia • 07/28/23
Compared to Estimates, Astrazeneca (AZN) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/28/23
AstraZeneca CFO denies geopolitics impacts the company's China business after spinoff rumorsCNBC • 07/28/23
NatWest adjusts to life after Rose, plus AstraZeneca and BA interims due on FridayProactive Investors • 07/27/23
AstraZeneca earnings update comes with shares regrouping after big tumble from peakProactive Investors • 07/21/23
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonMarket Watch • 07/18/23